Recently, extensive studies have focused on EGCG, a major component in GTPs, mediated DNMTs and HAT inhibitory activity in various cancer cells, including breast cancer cells [13], [21], [24]. The gene discussed is TMPRSS11D; the disease is breast carcinoma.